US Congress Senate Bill 1132

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on April 15 2021 - 25% progression
Action: 2021-04-15 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin. Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement. This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals. The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.

EPI Act Ending Pricey Insulin Act

Sen. John Kennedy [R-LA]

Date	Chamber	Action
2021-04-15	Senate	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Type	Source
Summary	https://www.congress.gov/bill/117th-congress/senate-bill/1132/all-info
Text	https://www.congress.gov/117/bills/s1132/BILLS-117s1132is.pdf